Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-09-27 23:31:43 - browse：3444

Drug shortages are a growing problem in the U.S., and a shortage of livesaving cancer drugs in particular has reached crisis levels.

On the latest episode of the “First Opinion Podcast,” oncologist Kristen Rice explains that drug shortages have been happening for several years but have been progressively worsening in the past few months. Oncologists are facing critical shortages of common, generic cancer medications and have even begun to ration care for certain patients who are able to delay treatment, according to Rice.

“Patients are already under a lot of stress — they’re dealing with a cancer diagnosis, and they’re terrified. The last thing they want to hear is that something that’s critical to controlling their cancer might not be available, and we’re wondering where the next dose is going to come from,” Rice said.

The conversation is based off Rice’s recent First Opinion, “Cancer drug shortages should have patients rioting in the streets.“

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： FDA approves first treatment for ultra

WSS

A single drug, study failures leave Anavex with nothing but cash

Trump's false claims about Georgia's 2020 election long debunked

Burning questions for the 2024 JPM Healthcare Conference

Trump's false claims about Georgia's 2020 election long debunked

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

Ukraine taking heavy casualties 10 weeks into its counteroffensive

hotspot

Wikipedia

focus

Tori Bowie and the unacceptable rates of Black maternal death

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

How to save PrEP access — and even expand it

Listen: Racing for gene therapy & a pioneering approval

Medicare proposal to cover medical devices draws a mixed reaction

Antibiotic resistance and the global rise in human conflict

BioMarin wins approval for gene therapy to treat hemophilia A

Goldman Sachs launches $650M fund for life science investments

Duchenne breakthrough therapy leaves behind pioneering families

Clinical trials must include more disabled people

leisure time

AdventHealth escalates lawsuit against insurance vendor Multiplan

UCB departs biotech trade group BIO

Antibiotic resistance and the global rise in human conflict

U.K. sequencing study surfaces new findings about tumor DNA

Ahead of JPM, here's who's profiting most in health care

ProMED sees offers of support, but its future remains unclear

hotspot

knowledge

entertainment

focus